提醒成功

搜索
产品规范 | |
---|---|
Type | In Vivo - Reseach Grade Antibody |
Host | CHO cells |
catalog# | B00036 |
Application | Flow cytometry, animal model study |
Aliases | Interleukin-2 receptor alpha chain, CD25, IL2RA, IDDM10, IL2R, TCGFR, p55, IMD41, interleukin 2 receptor subunit alpha |
Size/Concentration | 1mg/5mg/20mg |
Isotype | Human IgG1 kappa |
Storage | Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles. |
Species Reactivity | Human |
Immunogen | Human CD25 |
Formulation | PBS, pH 7.4 |
Description |
---|
Daclizumab Biosimilar uses the same protein sequences as the therapeutic antibody daclizumab. Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable framework regions of the Eu myeloma antibody. The murine sequences were derived from the complementarity-determining regions of a murine anti-Tac antibody. Daclizumab binds with high-affinity to the Tac subunit of the high-affinity IL-2 receptor complex and inhibits IL-2 binding. The IL-2 receptor (Tac) subunit is expressed on activated but not resting lymphocytes. |
Daclizumab Biosimilar, CD25 Monoclonal Antibody B00036
规格:
- 1mg
- 5mg
- 20mg
数量:
-
+
说明书:


¥3250
-
咨询
-
收藏

